Discussing if the departure of U.S. CEO Bill Simon means a shakeup down the road for Wal-Mart, with Budd Bugatch, Raymond James & Associates, and CNBC's Courtney Reagan.» Read More
Citigroup said it is combining its investment banking and alternative investments units into one division led by a former Morgan Stanley executive.
“Power Lunch” is in Seattle to focus on the things that put the Pacific Northwest on the map, including the Internet and socially-conscious energy. Here's what some of the guests on the program are saying.
McDonald's on Friday forecast third-quarter earnings above the average Wall Street estimate as September same-store sales rose 5.9 percent on strength in Asia.
The chief financial officer of General Electric said Friday he is "not losing sleep" over the possible slowing of the U.S. economy, driven by troubles in the housing market.
Indra Nooyi remains confident Pepsi will perform even with raw costs going higher. But Cramer is concerned.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Retailer J.C. Penney recalled thousands of Winnie-the-Pooh doll play sets,wooden art boxes and horse-themed holiday ornaments because of unsafe levels of lead paint, the US Consumer Product Safety Commission said Thursday.
ConAgra Foods said on Thursday that it was voluntarily recalling all varieties of Banquet brand frozen pot pies and all varieties of store brand frozen pot pies following concerns that its poultry pot pie products may be linked to an outbreak of salmonella.
I don’t own any stock. That’s not by choice, but by CNBC edict. I just want that out there. Reporters are not allowed to own stock, unless it’s GE (parent company) in the 401K, because we report on companies constantly, and there cannot be any appearance of bias for gain, etc. We report on companies, we do not run them. That’s my preface to this post.
AT&T Inc. said Thursday that the head of its wireless unit, Stan Sigman, was retiring, and it appointed Ralph de la Vega as his successor.
Need proof the Big 3 may be on the verge of doing some good, perhaps even great things? Check out the latest management coup with Ford hiring Jim Farley away from Toyota to become the U.S. automaker's main man running marketing and communications.
Late yesterday an FDA panel of outside experts unanimously recommended the agency approve Medtronic's drug-coated stent called, "Endeavor". Unlike drugs, there is no telegraphed date for an agency decision, but analysts think the FDA will approve the device by the end of the year or early next year.
Virgin Mobile USA, a venture of Sprint Nextel and Richard Branson's Virgin Group, raised $412.5 million on Wednesday, with an initial public offering that priced at the low end of expectations.
Melanoma -- a type of skin cancer -- is the most common form of cancer. It can spread very quickly and the prognosis often is not good. The American Cancer Society estimates that nearly 60,000 new cases of melanoma will be diagnosed this year and more than 8,000 patients will die. You can find out more about it on the ACS's website.
The charitable trust that controls Milton Hershey's fortune and The Hershey Co., the U.S. chocolate company he founded, said Tuesday it is not satisfied with the company's lackluster performance, and is working to improve it.
A man walked into a Giant Eagle supermarket in Pittsburgh Saturday and allegedly tried to change a $1 million bill. The clerk became "suspicious" (really? why is that?), and turned the bill over to the manager. The man with the mill bill got angry and then got arrested. He reportedly had no identification on him. I suspect he was just another disgraced CEO on the run, and that bill was no fake!
An analysis of executive compensation disclosures by 350 companies found it "difficult" to understand how companies used performance targets to set pay levels, according to a U.S. Securities and Exchange Commission staff review released on Tuesday.
As we head into the thick of earnings season some analysts are putting out their preview notes for clients. And a couple of interesting ones about the kings of biotech, Genentech and Amgen, have come into my inbox over the past couple of days. Genentech reports after the bell next Monday, October 15. And Amgen comes out, also after the bell, ten days later on the 25th.
US Treasury debt prices were steady early Tuesday as investors looked ahead to the release of minutes from the Federal Reserve's policy meeting last month when the central bank cut benchmark interest rates.
Facing rising pressure from investors, wireless carrier Sprint Nextel said its chairman and chief executive will leave the company immediately and that 2007 earnings and revenue are likely to be below previous forecasts.
This morning, the world's second biggest drug company, GlaxoSmithKline, announced that Andrew Witty will replace JP Garnier as CEO at the end of next May. It's been known for a while that Garnier would be retiring next year, and the question was who would be tapped to succeed him.